DKSH Management Ltd.
/ Key word(s): Takeover
Media release DKSH has signed an agreement to acquire Bio-Strategy Limited (“Bio-Strategy”), the largest independent distributor of scientific instruments in Australia and New Zealand. With this acquisition, DKSH grows its Scientific Instrumentation business in line with Business Unit Technology’s strategy to build resilience and deliver profitable growth. Zurich, Switzerland, November 2, 2023 – DKSH has announced today that it signed an agreement for the acquisition of Bio-Strategy, the largest independent distributor of scientific instruments in Australia and New Zealand, focusing primarily on life sciences, medical & healthcare and environment & agriculture segments.
Established 2003 and based in Melbourne, Bio-Strategy generates net sales of more than CHF 40 million1 at good profitability. With a team of over 100 people, the company serves renowned blue chip clients and distributes products and services to around 1,200 customers. DKSH acquires 100% of the business and its management team and employees will join DKSH’s Business Unit Technology.
Hanno Elbraechter, Head Business Unit Technology at DKSH, commented: “I am delighted with the acquisition of Bio-Strategy as an important addition to DKSH. The specific industry and application knowledge of the company will help us to solidify our position in two of Asia Pacific’s key markets. While complementing both DKSH Technology’s product portfolio and regional presence, the acquired expertise will enable us to create added value for our clients and customers.”
John Chesterfield, CEO of Bio-Strategy, said: “We are pleased about the combination with DKSH, one of Asia’s leading technology distribution players, marking the next big step in our 20-year journey. In addition to a wider regional reach and an enlarged product and service portfolio, our clients, customers, employees, and business partners will benefit from various synergies. We are excited about our shared future, to leverage our common expertise and to continue successfully serving our stakeholders.”
The closing of the transaction is expected during the fourth quarter of 2023 and is subject to certain conditions.
1 Exchange rate 1 Swiss Franc / 1.88 NZD For further information, please contact:
DKSH Holding Ltd.
Till Leisner Head, Group Investor & Media Relations, Sustainability Phone +41 44 386 7315
Melanie Grüter Manager Group Media Relations Phone +41 44 386 7211
End of Media Release |
Language: | English |
Company: | DKSH Management Ltd. |
Wiesenstrasse 8 | |
8008 Zurich | |
Switzerland | |
Phone: | 044 386 72 72 |
E-mail: | media@dksh.com |
Internet: | www.dksh.com |
ISIN: | CH0126673539 |
Valor: | 12667353 |
Listed: | SIX Swiss Exchange |
EQS News ID: | 1763077 |
End of News | EQS News Service |
|
1763077 02.11.2023 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.